Kjell Erik Julius Håkansson

Medicin og biovidenskab

1. 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole 6%
2. Absenteeism 10%
3. Adrenal Cortex Hormones 45%
4. Antidepressive Agents 14%
5. Anxiety 5%
6. Asthma 100%
7. Azithromycin 20%
8. Biological Products 11%
9. Biological Therapy 20%
10. Bronchiectasis 21%
11. Cardiovascular Diseases 5%
12. Chronic Obstructive Pulmonary Disease 33%
13. Cohort Studies 42%
14. Coronavirus 19%
15. Costs and Cost Analysis 5%
16. Delivery of Health Care 6%
17. Denmark 8%
18. Depression 7%
19. Drive 8%
20. Education 5%
21. Eosinophils 9%
22. Hospital Mortality 7%
23. Hospitalization 7%
24. Hydroxychloroquine 33%
25. Hydroxymethylglutaryl-CoA Reductase Inhibitors 16%
26. Income 8%
27. Inflammation 6%
28. Interleukin-5 9%
29. Meta-Analysis 7%
30. Mood Disorders 5%
31. Mortality 20%
32. Outpatients 12%
33. Patient Readmission 9%
34. Placebos 6%
35. Prescriptions 5%
36. Prospective Studies 5%
37. Quality of Life 5%
38. Randomized Controlled Trials 8%
39. Referral and Consultation 6%
40. Rheumatoid Arthritis 6%
41. Severe Acute Respiratory Syndrome 10%
42. Social Class 9%
43. Systematic Reviews 6%
44. Therapeutics 5%
45. Tobacco 7%
46. Urokinase Plasminogen Activator Receptors 11%
47. Young Adult 20%